Q3 Revenue Collapses 72.5% as European Marketing Network Keeps Shrinking
INVU sits 64% above its 52-week low of $0.011 on light trading volume (0.2× avg).
Summary
Investview's Q3 net revenue fell 72.5% year-over-year to $2.2 million, extending the same collapse that cut Q2 revenue 73% to $2.5 million. The decline traces to the continued contraction of its European marketing network after a regulatory decision in Poland, plus Renu Laboratories dropping higher-volume, lower-margin customer arrangements. The reported $9 million net profit is not operating strength: it comes mainly from the sale of an equity investment, while the core business lost $2.1 million from operations in the quarter. Management also repurchased 2 million shares in Q3 and now targets initial commercial operations for its pre-revenue Opencash brokerage platform by the end of Q2 2027, contingent on regulatory and operational readiness. The story is a shrinking top line with no operating turnaround yet; the only forward item with a date is the Opencash launch target.
At the time of this announcement, INVU was trading at $0.02 on OTC in the Finance sector, with a market capitalization of approximately $33.1M. The 52-week trading range was $0.01 to $0.03. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.